Skip to content

PERPHARM

In bankruptcy Public limited companyfounded 2002Rue Pont-à-la-Faulx 26-28, 7600 PéruwelzKBO/BCE: BE 0478.611.658 subsidiary of RISSPHAR

Annual accounts 2022

full format, filed on 23-01-2024, 176 days late
€320,637
▼ 7.0%
-€129,180
▼ €168,345
-€145,279
▼ €170,045
-€92,265
▼ €215,711
0.8%
▼ 7.9 percentage points
0.91
▼ 0.30

The turnover shown is an estimate from the gross margin.

Turnover ≈ €1.1m. Estimated: probably between €870,000 and €1.8m.

Balance sheet

balance sheet total €2.0m on 31-12-2022
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

0.8%

Higher than 14% of 6,519 companies in 2022.

0.91

Higher than 21% of 6,469 companies in 2022.

-7.2%

Higher than 13% of 6,482 companies in 2022.

PERPHARM Middle half of the sector 80% of the sector Full accounts in retail trade (NACE 47)

Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: middle half · Working capital: bottom quarter · Staff: middle half

Staff

€46,589

Staff costs divided by the average number of full-time equivalents.

-2 people

people who joined people who left

In 2022, 4 people joined and 6 left.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20222021202020192018201720162015201420132012201120102009200820072006
Balance sheet: assets
20/58 2.0m1.9m884,013799,337656,536403,974414,608670,018663,074577,959462,384541,698564,120671,258670,689686,331669,271
21/28 1.1m1.2m285,611325,425299,10513,05020,12126,89033,23519,04119,92366,768120,972170,577227,256287,346338,917
21 ---1,0432,086------30,00070,000110,000150,000190,000230,000
22/27 1.1m1.2m284,122322,893295,5309,76116,83223,60129,94615,75216,63433,31947,60357,33776,85696,946108,297
22 923,410970,137124,427138,180135,707------------
23 167,055162,128134,540151,315118,8123,3355,1176,6298,5459,52510,81314,08011,2528,2267,9339,46411,002
24 18,71919,47625,15433,39941,0116,42611,71416,97221,4006,2275,82119,23936,35149,11168,92387,48396,921
28 1,4891,4891,4891,4891,4893,2893,2893,2893,2893,2893,2893,4493,3693,240400400620
29/58 914,790710,411598,402473,912357,430390,924394,487643,128629,839558,918442,461474,930443,148500,681443,433398,985330,354
3 313,821271,052279,833243,341164,219113,306125,498136,792120,594111,98296,954118,388117,668100,51393,83295,69979,569
30/36 313,821271,052279,833243,341164,219113,306125,498136,792120,594111,98296,954118,388117,668100,51393,83295,69979,569
40/41 423,207402,307276,546186,121166,95092,58586,269343,989334,190307,607258,488219,761207,761219,644195,985150,947126,429
40 161,394191,789147,247143,643129,62574,76180,156331,579329,352302,278255,637217,741187,586170,501180,113149,694125,750
41 261,813210,518129,29942,47837,32517,8236,11312,4094,8385,3292,8512,02020,17549,14315,8721,253679
54/58 173,60232,86838,75740,37526,262143,512131,849115,779132,547101,97350,71382,20284,423122,25899,977106,27580,858
490/1 4,1604,1833,2674,075-41,52050,87146,56942,50837,35536,30654,57933,29758,26653,63946,06443,498
Balance sheet: equity and liabilities
10/49 2.0m1.9m884,013799,337656,536403,974414,608670,018663,074577,959462,384541,698564,120671,258670,689686,331669,271
10/15 15,509160,788136,023158,167119,101135,704104,61959,85744,22319,225-57,486-75,530-58,83723,525-13,175-56,793-105,299
10/11 62,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,000
10 62,00062,000---------------
100 62,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,00062,000
13 6,2006,2006,2006,2006,2006,2006,2006,2006,200--------
130/1 6,2006,2006,200--------------
130 6,2006,2006,2006,2006,2006,2006,2006,2006,200--------
14 -52,69192,58867,82389,96750,90167,50436,419-8,343-23,977-42,775-119,486-137,530-120,837-38,476-75,175-118,793-167,299
17/49 2.0m1.7m747,990641,170537,434268,270309,989610,161618,850558,735519,870617,228622,957647,733683,864743,124774,571
17 1.0m1.1m349,309384,671212,5493,62136,14469,02074,64770,86382,83332,389107,209164,119254,755301,887356,524
170/4 752,899826,958207,309284,671112,5493,62136,14469,02074,64770,86382,83332,389107,209164,119254,755301,887356,524
178/9 250,000283,333142,000100,000100,000------------
42/48 1.0m586,964398,681256,499324,530264,649273,845541,141544,203487,871437,037584,839515,748483,614429,109424,389398,462
42 82,393112,04379,87482,79119,7794,26129,17229,08326,93436,96439,218157,129146,936149,52091,35097,95884,579
43 170,000170,000---------------
430/8 170,000170,000---------------
44 412,558247,449204,422132,518262,982202,219196,915435,772448,926427,450385,308407,712342,517320,393329,818313,753290,227
440/4 412,558247,449204,422132,518262,982202,219196,915435,772448,926427,450385,308407,712342,517320,393329,818313,753290,227
45 68,19156,62239,27028,27729,35653,55144,42931,28623,34323,45712,51119,99826,29513,7017,94112,67817,263
450/3 15,35810,4957,6301,1645,40626,33120,7785,1442,4383,6951,4204,9291,8406591611742,011
454/9 52,83346,12731,64027,11323,95027,22023,65126,14220,90519,76211,09115,06924,45513,0417,78012,50415,253
47/48 273,91385175,11612,91312,4134,6183,32845,00045,000-------6,392
492/3 -5,596--355----------16,84819,584
Income statement
76A -------1,600-----84---
9900 320,637344,900273,965245,779167,551189,639211,702199,841214,390200,235135,032165,525122,642189,142183,428223,471202,082
62 358,736244,171156,655152,027136,446131,293133,048121,773129,936113,88562,820107,877126,27474,73558,07488,68395,581
630 88,57256,67451,46648,94346,5417,8068,1138,90410,5586,66447,30063,65563,64661,63062,52364,87762,397
640/8 2,5084,8901466185493204958889479639901,2501,216891520265157
66A -----507-------200---
9901 -129,18039,16565,69844,192-15,98549,71270,04668,27672,94978,72223,923-7,258-68,49451,88662,31169,64643,947
75/76B 121162932121601413558347226307579502449115
75 121162932121601413558347226307579502449115
65/66B 16,22014,4165,3895,1471,0071,0491,5811,5171,8552,0955,9279,66114,17515,57418,76021,58922,611
65 16,22014,4165,3895,1471,0071,0491,5811,5171,8552,0955,9279,66114,17515,57418,76021,58922,611
9903 -145,27924,76660,60139,066-16,77648,66368,47968,37271,14876,71118,044-16,693-82,36236,77544,05348,50621,451
67/77 --7,630--17217,57823,7167,7391,149----76434--80
9904 -145,27924,76652,97239,066-16,60331,08544,76260,63369,99976,71118,044-16,693-82,36236,69943,61848,50621,531
9905 -145,27924,76652,97239,066-16,60331,08544,76260,63369,99976,71118,044-16,693-82,36236,69943,61848,50621,531
Appropriation of the result
9906 -52,69192,588142,93989,96750,90167,50436,41936,65727,223-42,775-119,486-137,530-120,837-38,476-75,175-118,793-167,299
14P 92,58867,823---------------
691/2 --------6,200--------
6920 --------6,200--------
694/7 --75,116----45,00045,000--------
694 --75,116--------------
695 -------45,00045,000--------
Social balance sheet
9087 7.76.33.83.43.43.43.83.41.53.42.333.71.71.62.33
Hours worked1013 12,36710,4686,7165,8285,9035,8726,2275,5055,2505,2093,8154,9165,8732,9771,7592,9063,987
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The accounts for 3 older financial years (2003-2005) were filed as documents without figures as data, scans for example.

The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2022 (PDF), filed on 23-01-2024.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2022 annual accounts filed 176 days after the deadline. Filed on 23 January 2024, deadline 31 July 2023 (7 months after the close on 31 December 2022, Companies Code art. 3:10). Source: NBB, 2024-00004871.

Financial year Type Filed Reference Document
31-12-2022 full format 23-01-2024 2024-00004871 PDF
31-12-2021 full format 12-07-2022 2022-20174011 PDF
31-12-2020 full format 14-07-2021 2021-36000271 PDF
31-12-2019 full format 24-08-2020 2020-44100482 PDF
31-12-2018 full format 29-08-2019 2019-54400506 PDF
31-12-2017 full format 30-08-2018 2018-54400099 PDF
31-12-2016 full format 24-08-2017 2017-46900505 PDF
31-12-2015 full format 31-08-2016 2016-53600468 PDF
31-12-2014 full format 31-08-2015 2015-52700436 PDF
31-12-2013 full format 29-08-2014 2014-51900414 PDF
31-12-2012 full format 30-08-2013 2013-52100444 PDF
31-12-2011 full format 20-08-2012 2012-42000265 PDF
31-12-2010 full format 21-06-2011 2011-18400073 PDF
31-12-2009 full format 09-07-2010 2010-28900582 PDF
31-12-2008 full format 31-08-2009 2009-71200399 PDF
31-12-2007 full format 26-08-2008 2008-62800243 PDF
31-12-2006 full format 17-07-2007 2007-41800185 PDF
31-12-2005 full format 31-05-2006 2006-17304184 PDF
31-12-2004 full format 26-08-2005 2005-65404709 PDF
31-12-2003 full format 27-10-2004 2004-75604597 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20222021202020192018201720162015201420132012201120102009200820072006
-40,60895,839117,16393,13530,55657,51978,15977,18083,50785,38671,22356,397-4,848113,516124,834134,523106,344
-56,70781,439104,43788,00929,93838,89252,87569,53780,55783,37565,34446,962-18,71698,329106,141113,38383,928
46,016924,29311,65175,263334,3961,2441,3432,55924,7525,7826159,45114,0414,8672,43213,5266,469
140,733-5,889-1,61814,113-117,25011,66316,071-16,76830,57351,260-31,488-2,221-37,83522,282-6,29925,417-
-92,265123,447199,721217,41332,900126,275120,642101,98785,63671,0475,424-109,909-72,60017,06614,324-25,405-68,108
0.8%8.6%15.4%19.8%18.1%33.6%25.2%8.9%6.7%3.3%-12.4%-13.9%-10.4%3.5%-2.0%-8.3%-15.7%
0.911.211.501.851.101.481.441.191.161.151.010.810.861.041.030.940.83
0.600.750.800.900.601.050.980.940.940.920.790.610.630.830.810.710.63
-10.595.504.054.511.982.9610.1913.9929.06---27.53---
-936.7%15.4%38.9%24.7%-13.9%22.9%42.8%101.3%158.3%399.0%---156.0%---
-7.2%1.3%6.0%4.9%-2.5%7.7%10.8%9.0%10.6%13.3%3.9%-3.1%-14.6%5.5%6.5%7.1%3.2%
-2.506.65---------------

EBIT margin: not included in this filing.

A ratio outside any meaningful range has been withheld (balance sheet total €2.0m, equity €15,509).

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202231-12-2021
Employees at the balance-sheet date79
full-time58
part-time21
in full-time equivalents6.28.5
7.76.3
On a permanent contract79
Joined44
Left61

Source: social balance sheet in the 2021 to 2022 annual accounts

Investments

fixed assets acquired
Item20222021
Tangible fixed assets€46,016€924,293
€88,572€56,674

Source: notes to the 2021 to 2022 annual accounts (statement of fixed assets)

Insights on PERPHARM

The operating result for 2022 is a loss of €129,180, after a profit of €39,165 in 2021. It is the lowest result since 2006.

Debt's share of the balance-sheet total rises from 91.4% to 99.2%. Equity is lower and debt is higher.